Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00856284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes
Study identification
- NCT ID
- NCT00856284
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 2,639 participants
Conditions and interventions
Conditions
Interventions
- Alogliptin Drug
- Glipizide Drug
- Metformin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2009
- Primary completion
- Sep 30, 2012
- Completion
- Sep 30, 2012
- Last update posted
- Dec 2, 2013
2009 – 2012
United States locations
- U.S. sites
- 94
- U.S. states
- 34
- U.S. cities
- 94
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Montgomery | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Pell City | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Sierra Vista | Arizona | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Artesia | California | — | — |
| Not listed | Chico | California | — | — |
| Not listed | Los Alamitos | California | — | — |
| Not listed | Mission Viejo | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Northridge | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Arvada | Colorado | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Ridgefield | Connecticut | — | — |
| Not listed | Waterbury | Connecticut | — | — |
| Not listed | Brooksville | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | North Miami Beach | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Opa-locka | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Savannah | Georgia | — | — |
| Not listed | Addison | Illinois | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Bloomington | Indiana | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Mishawaka | Indiana | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Munfordville | Kentucky | — | — |
| Not listed | Marrero | Louisiana | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Elkridge | Maryland | — | — |
| Not listed | Oxon Hill | Maryland | — | — |
| Not listed | North Dartmouth | Massachusetts | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Flint | Michigan | — | — |
| Not listed | Picayune | Mississippi | — | — |
| Not listed | City of Saint Peters | Missouri | — | — |
| Not listed | Springfield | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | New Windsor | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Fargo | North Dakota | — | — |
| Not listed | Beachwood | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Willoughby Hills | Ohio | — | — |
| Not listed | Zanesville | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Havertown | Pennsylvania | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Tipton | Pennsylvania | — | — |
| Not listed | Anderson | South Carolina | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | New Tazewell | Tennessee | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Hurst | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Spring | Texas | — | — |
| Not listed | Temple | Texas | — | — |
| Not listed | Midvale | Utah | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Lewisburg | West Virginia | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 167 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00856284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2013 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00856284 live on ClinicalTrials.gov.